Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 22:22:35 - browse：694

Several amyloid plaques forming between neurons in a brain — Amyloid plaques forming between neurons. Adobe

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest.

The drug, called Leqembi, was developed by Eisai, the Japanese pharmaceutical company, and sold in partnership with Biogen. It previously secured conditional approval in January. The FDA’s decision will broaden patient access to the drug under the Medicare program and is likely to boost sales, even as Leqembi’s benefits and safety risks continue to be a source of debate.

Leqembi’s full, or traditional, approval was supported by results of a large clinical trial in which the drug slowed the rate of cognitive and functional decline by 27% compared to a placebo. Leqembi also beat placebo on a series of secondary measures of Alzheimer’s, and it had a dramatic effect on clearing toxic brain plaques called beta-amyloid, which play a role in the progression of the disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

WSS

Inaction leaves children at risk from dangerous chemotherapy drug

Explaining an after

Update the Apgar Score to remove skin color

To bolster infectious disease surveillance, genomics powerhouses team up

Travis Kelce and the trap of celebrity vaccine endorsements

Update the Apgar Score to remove skin color

hotspot

Wikipedia

knowledge

Apple is now the first public company to be valued at $3 trillion

Mass General, Mayo Clinic look to monetize custom

Guidelines to prevent youth baseball injuries need more muscle

Future doctors need a strong humanities education

Hepatitis C has a cure — but many Americans still lack access to it

Humans aren't the only ones with an imagination. Rats have it too

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Pumping milk in bathrooms at health conferences is common

Medical records are filled with copy

Printout prescription drug information shouldn’t go digital

knowledge

Maisha Meds is a PBM, but don't call it that

To bolster infectious disease surveillance, genomics powerhouses team up

To bolster infectious disease surveillance, genomics powerhouses team up

Gene therapy’s promise and the high cost of hope

Lung cancer screening guidelines updated for cigarette smokers

Readout Newsletter: Parkinson's study, Gilead, CG Oncology

leisure time

leisure time

knowledge

focus